Clinical trial
Inpatient Safety and Feasibility Evaluation of the Zone-MPC Control Algorithm Integrated Into the APS APP
NCT03504046 is registered in ClinicalTrials.gov with Sansum Diabetes Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inpatient Safety and Feasibility Evaluation of the Zone-MPC Control Algorithm Integrated Into the APS APP
- Lead sponsor
- Sansum Diabetes Research Institute
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2018
- Completion date
- September 4, 2018
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes mellitus